IPAR vs JAZZ · P/E 17, rev $1.32B vs P/E 1988, rev $4.07B
Inter Parfums Inc (IPAR) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Inter Parfums Inc (IPAR) is a household & personal products company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported IPAR revenue for 2023-12-31 was $1.32B. Net income was $187.8M. Revenue was up 21.3% from 2022-12-31 to 2023-12-31. IPAR currently screens at market cap $2.92B and trailing P/E 17.3.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
IPAR currently screens at market cap $2.92B and trailing P/E 17.3. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the IPAR and JAZZ stock pages for the full models.
Not investment advice.